VERICEL CORPORATION - COMMON STOCK
36.45
26-8月-25 13:45:00
15 分の遅延
株式
+0.66
+1.84%
本日の幅
35.53 - 36.83
ISIN
N/A
ソース
NASDAQ
-
04 1 2023 05:34:47 提供 Nasdaq GlobeNewswire
-
Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults
29 12 2022 10:45:00 提供 Nasdaq GlobeNewswire
-
10 11 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Vericel Reports Third Quarter 2022 Financial Results
09 11 2022 04:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022
26 10 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Ladenburg Thalmann Healthcare Conference
22 9 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
06 9 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Vericel Reports Second Quarter 2022 Financial Results
03 8 2022 04:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022
20 7 2022 05:30:01 提供 Nasdaq GlobeNewswire
-
Vericel Reports First Quarter 2022 Financial Results
04 5 2022 04:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022
20 4 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
15 3 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022
01 3 2022 05:30:01 提供 Nasdaq GlobeNewswire
-
Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer
24 2 2022 13:45:00 提供 Nasdaq GlobeNewswire
-
24 2 2022 04:55:00 提供 Nasdaq GlobeNewswire
-
Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022
10 2 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
02 2 2022 13:05:00 提供 Nasdaq GlobeNewswire
-
04 1 2022 05:30:00 提供 Nasdaq GlobeNewswire
-
11 11 2021 05:30:00 提供 Nasdaq GlobeNewswire